Literature DB >> 29058707

Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Driton Vela1.   

Abstract

Hepcidin is the main regulator of iron metabolism in tissues. Its serum levels are mostly correlated with the levels of hepcidin expression from the liver, but local hepcidin can be important for the physiology of other organs as well. There is an increasing evidence that this is the case with cardiac hepcidin. This has been confirmed by studies with models of ischemic heart disease and other heart pathologies. In this review the discussion dissects the role of cardiac hepcidin in cellular homeostasis. This review is complemented with examination of the role of systemic hepcidin in heart disease and its use as a biochemical marker. The relationship between systemic vs local hepcidin in the heart is important because it can help us understand how the fine balance between the actions of two hepcidins affects heart function. Manipulating the axis systemic/cardiac hepcidin could serve as a new therapeutic strategy in heart diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29058707     DOI: 10.1038/labinvest.2017.111

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  113 in total

1.  Hepcidin--a well-known iron biomarker with prognostic implications in chronic kidney disease.

Authors:  Martin Wagner; Damien Ashby
Journal:  Nephrol Dial Transplant       Date:  2013-09-17       Impact factor: 5.992

2.  Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients.

Authors:  Yao-Peng Hsieh; Ching-Hui Huang; Chia-Ying Lee; Hung-Lin Chen; Ching-Yuang Lin; Chia-Chu Chang
Journal:  World J Nephrol       Date:  2013-05-06

3.  T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice.

Authors:  Sirinart Kumfu; Siriporn Chattipakorn; Somdet Srichairatanakool; Jongkolnee Settakorn; Suthat Fucharoen; Nipon Chattipakorn
Journal:  Eur J Haematol       Date:  2010-12-29       Impact factor: 2.997

4.  Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients.

Authors:  Neelke C van der Weerd; Muriel P C Grooteman; Michiel L Bots; Marinus A van den Dorpel; Claire H den Hoedt; Albert H A Mazairac; Menso J Nubé; E Lars Penne; Jack F M Wetzels; Erwin T Wiegerinck; Dorine W Swinkels; Peter J Blankestijn; Piet M Ter Wee
Journal:  Nephrol Dial Transplant       Date:  2012-11-11       Impact factor: 5.992

5.  Sex differences in iron status and hepcidin expression in rats.

Authors:  Wei-Na Kong; Qiao-Man Niu; Lan Ge; Nan Zhang; Shao-Feng Yan; Wei-Bin Chen; Yan-Zhong Chang; Shu-E Zhao
Journal:  Biol Trace Elem Res       Date:  2014-06-26       Impact factor: 3.738

6.  Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia.

Authors:  David B Bregman; David Morris; Todd A Koch; Andy He; Lawrence T Goodnough
Journal:  Am J Hematol       Date:  2013-01-18       Impact factor: 10.047

7.  Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart.

Authors:  Wenjing Xu; Tomasa Barrientos; Lan Mao; Howard A Rockman; Anthony A Sauve; Nancy C Andrews
Journal:  Cell Rep       Date:  2015-10-08       Impact factor: 9.423

8.  Iron status in patients with chronic heart failure.

Authors:  Ewa A Jankowska; Jolanta Malyszko; Hossein Ardehali; Ewa Koc-Zorawska; Waldemar Banasiak; Stephan von Haehling; Iain C Macdougall; Guenter Weiss; John J V McMurray; Stefan D Anker; Mihai Gheorghiade; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2012-11-23       Impact factor: 29.983

9.  The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.

Authors:  Xiao Hu Ge; Qin Wang; Zhong Ming Qian; Li Zhu; Fang Du; Wing Ho Yung; Lei Yang; Ya Ke
Journal:  J Nutr Biochem       Date:  2008-11-22       Impact factor: 6.048

10.  Iron and Sex Cross Paths in the Heart.

Authors:  Jason S Shapiro; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2017-01-23       Impact factor: 5.501

View more
  11 in total

Review 1.  In-depth review: is hepcidin a marker for the heart and the kidney?

Authors:  Rengin Elsurer Afsar; Mehmet Kanbay; Avsin Ibis; Baris Afsar
Journal:  Mol Cell Biochem       Date:  2021-05-04       Impact factor: 3.396

2.  Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology.

Authors:  Alessandra Bolotta; Antonella Pini; Provvidenza M Abruzzo; Alessandro Ghezzo; Alessandra Modesti; Tania Gamberi; Carla Ferreri; Francesca Bugamelli; Filippo Fortuna; Silvia Vertuani; Stefano Manfredini; Cinzia Zucchini; Marina Marini
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-03

Review 3.  Luspatercept: A Gigantic Step in the Treatment of Transfusion-Dependent β-Thalassemia Patients-a Quick Review.

Authors:  Hadi Darvishi-Khezri; Hossein Karami
Journal:  Adv Ther       Date:  2021-03-04       Impact factor: 3.845

4.  Long-term changes in plasma proteomic profiles in premenopausal and postmenopausal Black and White women: the Atherosclerosis Risk in Communities study.

Authors:  Duke Appiah; Pamela J Schreiner; James S Pankow; Guy Brock; Weihong Tang; Faye L Norby; Erin D Michos; Christie M Ballantyne; Aaron R Folsom
Journal:  Menopause       Date:  2022-08-20       Impact factor: 3.310

Review 5.  Extrahepatic hepcidin production: The intriguing outcomes of recent years.

Authors:  Raêd Daher; Thibaud Lefebvre; Hervé Puy; Zoubida Karim
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

6.  Expression of Iron Metabolism Proteins in Patients with Chronic Heart Failure.

Authors:  Bogna Kozłowska; Barbara Sochanowicz; Leszek Kraj; Małgorzata Palusińska; Piotr Kołsut; Łukasz Szymański; Sławomir Lewicki; Witold Śmigielski; Marcin Kruszewski; Przemysław Leszek
Journal:  J Clin Med       Date:  2022-02-05       Impact factor: 4.241

Review 7.  Intravenous iron therapy and the cardiovascular system: risks and benefits.

Authors:  Lucia Del Vecchio; Robert Ekart; Charles J Ferro; Jolanta Malyszko; Patrick B Mark; Alberto Ortiz; Pantelis Sarafidis; Jose M Valdivielso; Francesca Mallamaci
Journal:  Clin Kidney J       Date:  2020-11-26

Review 8.  Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function?

Authors:  Jovana Knezevic; Christina Starchl; Adelina Tmava Berisha; Karin Amrein
Journal:  Nutrients       Date:  2020-06-12       Impact factor: 5.717

Review 9.  Structural and functional abnormalities in iron-depleted heart.

Authors:  Kamil A Kobak; Malwina Radwańska; Magdalena Dzięgała; Monika Kasztura; Krystian Josiak; Waldemar Banasiak; Piotr Ponikowski; Ewa A Jankowska
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

Review 10.  Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.

Authors:  Francesca Vinchi
Journal:  Antioxid Redox Signal       Date:  2021-03-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.